CMPAX
Price
$28.19
Change
-$0.23 (-0.81%)
Updated
Nov 14 closing price
PMAQX
Price
$47.96
Change
-$0.50 (-1.03%)
Updated
Nov 14 closing price
Ad is loading...

CMPAX vs PMAQX

Header iconCMPAX vs PMAQX Comparison
Open Charts CMPAX vs PMAQXBanner chart's image
Calvert Small/Mid-Cap A
Price$28.19
Change-$0.23 (-0.81%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$47.96
Change-$0.50 (-1.03%)
VolumeN/A
CapitalizationN/A
CMPAX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMPAX vs. PMAQX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPAX is a Buy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30B vs. CMPAX (64M). PMAQX pays higher dividends than CMPAX: PMAQX (0.10) vs CMPAX (0.00). CMPAX was incepted earlier than PMAQX: CMPAX (57 years) vs PMAQX (8 years). CMPAX is a more actively managed with annual turnover of: 43.00 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than CMPAX: PMAQX (0) vs CMPAX (1000). PMAQX annual gain was more profitable for investors over the last year : 32.12 vs. CMPAX (23.66). PMAQX return over 5 years is better than : 55.10 vs. CMPAX (16.86).
CMPAXPMAQXCMPAX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence57 years8 years-
Gain YTD14.65426.39556%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets64M30B0%
Annual Yield % from dividends0.000.10-
Returns for 1 year23.6632.1274%
Returns for 3 years-10.786.88-157%
Returns for 5 years16.8655.1031%
Returns for 10 years26.75N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIXT1.65-0.03
-1.79%
Lixte Biotechnology Holdings
ATRO16.49-0.38
-2.25%
Astronics Corp
LFST7.22-0.18
-2.43%
LifeStance Health Group
CVNA239.98-6.77
-2.74%
Carvana Co
IPSC1.33-0.08
-5.67%
Century Therapeutics